scispace - formally typeset
C

Chaussain Jl

Researcher at French Institute of Health and Medical Research

Publications -  22
Citations -  3034

Chaussain Jl is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Precocious puberty & Bone age. The author has an hindex of 10, co-authored 22 publications receiving 2821 citations. Previous affiliations of Chaussain Jl include University of Valladolid.

Papers
More filters
Journal ArticleDOI

Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54

TL;DR: The present study shows that loss of function of GPR54 is a cause of IHH, and it identifies GPR 54 and possibly KiSS1 protein-derived peptide as playing a major and previously unsuspected role in the physiology of the gonadotropic axis.
Journal ArticleDOI

Precocious puberty and statural growth

TL;DR: It is shown that GnRH agonists restore adult height in children when it is compromised by precocious puberty, and the most appropriate time for interrupting the treatment is still controversial.
Journal ArticleDOI

Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma

TL;DR: Analysis of constitutional and tumor genotypes in nine cases of hereditary Wilms tumor and in three unrelated cases of familial adrenocortical carcinoma suggest that region 11p15.5 may carry a non-tissue-specific gene that could be involved in genetic predisposition, in tumor progression, or in both.
Journal ArticleDOI

Gonadotropin and α-Subunit Secretion During Long Term Pituitary Suppression by D-Trp6-Luteinizing Hormone-Releasing Hormone Microcapsules as Treatment of Precocious Puberty*

TL;DR: The sustained response of Gn alpha to LHRH demonstrates that gonadotroph cell L HRH receptors are still responsive to LhrH during treatment with a LHRh agonist, and the large discrepancy between RIA and IRMA LH values suggests the secretion of unusual LH molecules which are recognized by RIA but not by IRMA.
Journal ArticleDOI

Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg).

TL;DR: In conclusion, leuprorelin 3-month depot efficiently inhibits the gonadotropic axis in 95% of children with central precocious puberty studied for a 6-month period, allowing the reduction of the number of yearly injections from 12 to 4.